LOADING
Comparing Apple Inc (AAPL) and Johnson & Johnson (JNJ) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AAPL | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.51T | $651.3B |
| P/E Ratio | 35.5 | 31.4 |
| Forward P/E | 32.5 | 23.2 |
| PEG Ratio | 2.49 | 4.73 |
| EPS | $8.72 | $8.62 |
| Revenue Growth (YoY) | 16.4% | 6.6% |
| Profit Margin | 27.6% | 21.5% |
| Return on Equity | 148.8% | 25.7% |
| Dividend Yield | 0.34% | 1.96% |
| Beta | 1.09 | 0.23 |
| 52-Week High | $344.27 | $276.47 |
| 52-Week Low | $223.86 | $170.33 |
| Volume | -- | -- |
Apple Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Apple Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.